CordenPharma Acquires AmbioPharm, Establishing U.S. Peptide Supply Chain with South Carolina Plant

CordenPharma will acquire AmbioPharm, thereby expanding its peptide production capabilities and establishing a fully U.S.-based supply chain with facilities like the South Carolina plant.

The acquisition, announced Monday, June 1, 2026, will allow CordenPharma to integrate AmbioPharm’s facilities into its existing network. The deal provides CordenPharma with a significant U.S. manufacturing presence through AmbioPharm’s South Carolina plant.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: June 1, 2026

Author

GOAI